関: ureter cancer

WordNet

either of a pair of thick-walled tubes that carry urine from the kidney to the urinary bladder

PrepTutorEJDIC

尿管(じん臓から膀胱(ぼうこう)に尿を送る筋肉質の管)
(体内にできる)新生物;腫瘍(しゅよう)

Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2012/09/09 21:34:48」(JST)

wiki en

[Wiki en表示]

A ureteral neoplasm is a type of tumor that can be primary, or associated with a metastasis from another site.^[1]

Treatment may involve removal of the kidney and ureter, or just the ureter.^[2]

Classification of cancers often is oriented around the embryological origin of the tissue. In some contexts, the primary division is at the border of kidney and ureter, and in other contexts, the primary division is between derivatives of the metanephric blastema and those of the ureteric bud. Because of this, neoplasia of the ureters are sometimes grouped with tumors of the renal pelvis.^[3]^[4]

References

^ Shimoyama Y, Ohashi M, Hashiguchi N et al. (September 2000). "Gastric cancer recognized by metastasis to the ureter". Gastric Cancer 3 (2): 102–105. doi:10.1007/PL00011693. PMID 11984719.
^ "Ureteral Cancer". http://www.fccc.edu/cancer/types/genitourinary/ureteral.html.
^ "Transitional Cell Cancer (Kidney/Ureter) Treatment - National Cancer Institute". http://www.cancer.gov/cancertopics/pdq/treatment/transitionalcell/patient/.
^ "Renal Pelvis and Ureter Cancer: Cancers of the Kidney and Urinary Tract: Merck Manual Home Health Handbook". http://www.merckmanuals.com/home/kidney_and_urinary_tract_disorders/cancers_of_the_kidney_and_urinary_tract/renal_pelvis_and_ureter_cancer.html.

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 尿管ステントの留置およびマネージメント placement and management of indwelling ureteral stents
2. 医原性尿菅損傷の外科的修復 surgical repair of an iatrogenic ureteral injury
3. 尿管結石のマネージメント management of ureteral calculi
4. 婦人科外科手術における尿路損傷：予防 urinary tract injury in gynecologic surgery prevention
5. 婦人科外科手術における尿路損傷：評価およびマネージメント urinary tract injury in gynecologic surgery evaluation and management

English Journal

Robotic Reconstructive Surgery for Ureteral Malignancy: Analysis of Efficacy and Oncologic Outcomes.

McClain PD, Mufarrij PW, Hemal AK.SourceWake Forest School of Medicine, Urology, Medical Center Boulevard Winston-Salem, NC 27157, Winston-Salem, North Carolina, United States, 27157, 8283373752; mcclain.pauld@gmail.com.
Journal of endourology / Endourological Society.J Endourol.2012 Jul 31. [Epub ahead of print]
Background and Purpose There have been previous reports of the utilization of robotic technology for the surgical treatment of ureteral neoplasms such as transitional cell carcinoma. These have lacked long term follow-up, been isolated cases, or focused on only the distal ureter. This investigati
PMID 22849289

Utility of MRI features for differentiation of retroperitoneal fibrosis and lymphoma.

Rosenkrantz AB, Spieler B, Seuss CR, Stifelman MD, Kim S.SourceDepartment of Radiology, NYU Langone Medical Center, 550 First Ave, TCH-HW202, New York, NY 10016, USA. asndrew.rosenkrantz@nyumc.org
AJR. American journal of roentgenology.AJR Am J Roentgenol.2012 Jul;199(1):118-26.
OBJECTIVE: The objective of our study was to retrospectively compare the MRI features of retroperitoneal fibrosis (RPF) and lymphoma presenting as confluent retroperitoneal soft tissue.MATERIALS AND METHODS: MRI studies of 31 patients (18 men, 13 women; mean age, 58.4 ± 15.8 [SD] years; 22 with RPF
PMID 22733902

Japanese Journal

Initial experience of functional imaging of upper urinary tract neoplasm by diffusion-weighted magnetic resonance imaging

YOSHIDA Soichiro,MASUDA Hitoshi,ISHII Chikako,SAITO Kazutaka,KAWAKAMI Satoru,KIHARA Kazunori
International journal of urology 15(2), 140-143, 2008-02-01
NAID 10021276712

腎孟尿管癌におけるp53,Ki-67,E-cadherin,β-cateninの免疫組織学的検討

辻本裕一,小森和彦,辻本正彦,波多野浩士,高田剛,本多正人,松宮清美,藤岡秀樹
日本泌尿器科學會雜誌 99(1), 1-6, 2008-01-20
(目的)31例の腎孟尿管癌について臨床病理学的・免疫組織学的に予後と膀胱内再発予測因子について検討を行った.(対象と方法)男性が19名,女性12名で,年齢は43歳から84歳,中央値は69歳であった.観察期間の中央値は79ヵ月であった.腎孟尿管癌組織を用いてp53,Ki-67,E-cadherin,β-cateninの免疫組織学的検討を行った.(結果・結論)31例の疾患特異的5年生存率は77.4%で …
NAID 110006548692